OncoRevive develops a nanotechnology-based liquid biopsy designed to identify cancer at its early stages. The startup’s platform offers cancer-detection options by examining protein, gene, and glycan biomarkers
Solution Effectiveness
OncoRevive enables health practitioners to get an accurate and comprehensive analysis of tumor biology for personalized medicine, slashing costs by 40%
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
$144K
Last Funding Amount
$144K
Last Funding Date
Nov 17, 2023
Startup Stage
Early-Stage
Lead Investors
Antler
People
Founders
Samira Sadeghi
CEO
Samira Sadeghi
Products
Demo Product or Complete Product?
Development
Future Plan
Investment Funding
Our project is focused on raising funds to advance the development and global deployment of our ground-breaking technology
